Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.

BACKGROUND Despite the frequent occurrence of bacteremia due to gram-negative organisms in patients with underlying permanent pacemakers (PPMs) or implantable cardioverter defibrillators (ICDs), the outcome and treatment of these patients has received scant attention. In patients with PPMs or ICDs who have Staphylococcus aureus bacteremia, 45% have PPM/ICD infection. METHODS We conducted a retrospective cohort study over a 7-year period to assess the clinical features and frequency of PPM/ICD infection in patients with gram-negative bacteremia, as well as the incidence of relapse in patients for whom the device was not removed. RESULTS Forty-nine patients were included in the study; 3 (6%) had either definite (2 patients) or possible (1 patient) PPM/ICD infection. Both patients with definite PPM/ICD infection had clear infection of the generator pocket. None of the other patients with alternate sources of bacteremia developed PPM/ICD infection. Thirty-four patients with retained PPM/ICD were observed for >12 weeks (median time, 759 days), and 2 (6%) developed relapsing bacteremia, although they each had alternative sources of relapse. CONCLUSIONS In sharp contrast to S. aureus infection, PPM/ICD infection in patients with gram-negative bacteremia was rare, and no patients appeared to have secondary PPM/ICD infection due to hematogenous seeding of the system. Despite infrequent system removal in these patients, relapsing bacteremia among patients who survived initial bacteremia was rarely seen. If secondary PPM/ICD infection occurs in patients with gram-negative bacteremia, it is either uncommon or it is cured with antimicrobial therapy despite device retention.

[1]  R. Holmes,et al.  Adherence of bacteria to heart valves in vitro. , 1975, The Journal of clinical investigation.

[2]  F. Raffi,et al.  Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Meyers,et al.  Bloodstream infections in the elderly. , 1989, The American journal of medicine.

[4]  B. Gersh,et al.  Permanent pacemaker infections: characterization and management. , 1981, The American journal of cardiology.

[5]  J. Matloff,et al.  Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode. The role of electrode design. , 1977, The Journal of thoracic and cardiovascular surgery.

[6]  Walter R Wilson,et al.  Nonvalvular cardiovascular device-related infections. , 2004, Clinical Infectious Diseases.

[7]  J. Phillips,et al.  The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. , 2005, The American journal of medicine.

[8]  V L Yu,et al.  Prosthetic Valve Endocarditis Resulting from Nosocomial Bacteremia: A Prospective, Multicenter Study , 1993, Annals of Internal Medicine.

[9]  R. Friedman,et al.  Recommendations for Extraction of Chronically Implanted Transvenous Pacing and Defibrillator Leads: Indications, Facilities, Training , 2000, Pacing and clinical electrophysiology : PACE.

[10]  A. Leatham,et al.  Septicemia in patients with an endocardial pacemaker. , 1979, The American journal of cardiology.

[11]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[12]  David Longworth,et al.  Diagnosis and Management of Infections Involving Implantable Electrophysiologic Cardiac Devices , 2000, Annals of Internal Medicine.

[13]  T. Nealon,et al.  Four hundred consecutive patients with permanent transvenous pacemakers. , 1975, The Journal of thoracic and cardiovascular surgery.

[14]  I. Lossos,et al.  Pacemaker endocarditis. Report of 44 cases and review of the literature. , 1994, Medicine.

[15]  C. Martí,et al.  Predictors of Mortality in Patients with Bacteremia: The Importance of Functional Status , 1998, Journal of the American Geriatrics Society.

[16]  Vance G. Fowler,et al.  Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.

[17]  T. Ferguson,et al.  The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. , 1996, The Journal of thoracic and cardiovascular surgery.

[18]  G. Bluhm Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. , 2009, Acta medica Scandinavica. Supplementum.

[19]  D Lacroix,et al.  Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.

[20]  Y. Han,et al.  New self‐expanding patent foramen ovale occlusion device , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  R. Darouiche Device-associated infections: a macroproblem that starts with microadherence. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  T. Pruett Staphylococcus aureus Bacteremia in Patients With Prosthetic Devices: Costs and Outcomes , 2006 .

[23]  R. Haug New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings , 1994 .

[24]  V. Fowler,et al.  Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. , 2005, The American journal of medicine.

[25]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.